CLS Holdings USA, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 13 - Commitment and Contingencies (Details)

Note 13 - Commitment and Contingencies (Details)					1 Months Ended	3 Months Ended	9 Months Ended		12 Months Ended
Note 13 - Commitment and Contingencies (Details)	Mar. 01, 2017 USD ($)	Jul. 20, 2016 USD ($)	Aug. 01, 2015 USD ($)	Oct. 01, 2014 USD ($)	Mar. 31, 2017 USD ($)	Feb. 28, 2017 USD ($) ft² a	Feb. 28, 2017 USD ($) ft² a	Feb. 29, 2016 USD ($)	May 31, 2016 USD ($) shares
Note 13 - Commitment and Contingencies (Details) [Line Items]
Debt Conversion, Original Debt, Amount						$ 460,000	$ 250,000	$ 0
Employee-related Liabilities, Current						128,750	128,750		$ 267,493
Allocated Share-based Compensation Expense							0	327,500
Chief Executive Officer [Member]
Note 13 - Commitment and Contingencies (Details) [Line Items]
Employment Agreement, Term				5 years
Officers' Compensation				$ 150,000					150,000
Deferred Compensation Arrangement with Individual, Description				performance bonus equal to 2% of CLS Labs’ annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary)
Share-based Compensation Arrangement by Share-based Payment Award, Description				annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million
Employee-related Liabilities, Current						112,500	112,500		$ 250,000
Chief Executive Officer [Member] \| Convertible Debt [Member] \| Unpaid Accrued Salary Converted to Convertible Note [Member]
Note 13 - Commitment and Contingencies (Details) [Line Items]
Debt Conversion, Original Debt, Amount		$ 250,000
Chief Operating Officer [Member]
Note 13 - Commitment and Contingencies (Details) [Line Items]
Employment Agreement, Term			5 years
Officers' Compensation			$ 150,000
Deferred Compensation Arrangement with Individual, Description			performance bonus equal to 2% of the Company’s annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary)
Share-based Compensation Arrangement by Share-based Payment Award, Description			annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million
Chief Operating Officer [Member] \| One Time Signing Bonus [Member]
Note 13 - Commitment and Contingencies (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) \| shares									250,000
Allocated Share-based Compensation Expense									$ 327,500
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period									1 year
Former Officer [Member]
Note 13 - Commitment and Contingencies (Details) [Line Items]
Employee-related Liabilities, Current						$ 16,250	$ 16,250		$ 16,250
Building [Member] \| Affiliated Entity [Member]
Note 13 - Commitment and Contingencies (Details) [Line Items]
Area of Real Estate Property (in Square Feet) \| ft²						42,392	42,392
Area of Land (in Acres) \| a						1.92	1.92
Operating Leases, Rent Expense							$ 139,827	$ 163,024
Subsequent Event [Member]
Note 13 - Commitment and Contingencies (Details) [Line Items]
Debt Conversion, Original Debt, Amount					$ 37,500
Subsequent Event [Member] \| Chief Executive Officer [Member] \| Convertible Debt [Member] \| Unpaid Accrued Salary Converted to Convertible Note [Member]
Note 13 - Commitment and Contingencies (Details) [Line Items]
Debt Conversion, Original Debt, Amount	$ 112,500